196 related articles for article (PubMed ID: 31707376)
1. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
[TBL] [Abstract][Full Text] [Related]
2. Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.
Suri V; Keepanaseril A; Aggarwal N; Vijayvergiya R
Indian J Med Sci; 2009 Sep; 63(9):411-4. PubMed ID: 19805921
[TBL] [Abstract][Full Text] [Related]
3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
[TBL] [Abstract][Full Text] [Related]
5. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report.
Merriman JB; Gonzalez JM; Rychik J; Ural SH
J Reprod Med; 2008 May; 53(5):357-9. PubMed ID: 18567282
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
7. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
[TBL] [Abstract][Full Text] [Related]
8. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
[No Abstract] [Full Text] [Related]
9. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
Agarwal A; Saha SC; Kaur A; Naganur S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
[TBL] [Abstract][Full Text] [Related]
10. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
11. [Fetal supraventricular tachycardia. Management].
Amiel C; Chau C; Millet V; Agher JP; Gamerre M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):284-8. PubMed ID: 8102147
[TBL] [Abstract][Full Text] [Related]
12. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
[TBL] [Abstract][Full Text] [Related]
13. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis.
Barjot P; Hamel P; Calmelet P; Maragnes P; Herlicoviez M
Acta Obstet Gynecol Scand; 1998 Mar; 77(3):353-8. PubMed ID: 9539287
[No Abstract] [Full Text] [Related]
14. Complete resolution of arrhythmia-induced hydrops fetalis in utero.
Narayanan M; Dhuka S; Alapati S; Kauffman RP
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33040036
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
Pradhan M; Manisha M; Singh R; Kapoor A
Fetal Diagn Ther; 2006; 21(1):72-6. PubMed ID: 16354980
[TBL] [Abstract][Full Text] [Related]
16. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
Tunca Sahin G; Beattie RB; Uzun O
Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
[TBL] [Abstract][Full Text] [Related]
17. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy.
Edwards A; Peek MJ; Curren J
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):110-2. PubMed ID: 10099764
[TBL] [Abstract][Full Text] [Related]
18. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
[TBL] [Abstract][Full Text] [Related]
19. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
[TBL] [Abstract][Full Text] [Related]
20. Resolution of hydrops fetalis despite persistent fetal tachycardia.
Silver LE; Platt LD; Santulli TV; Carlson DE
J Ultrasound Med; 2001 Oct; 20(10):1141-5. PubMed ID: 11587022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
